Read More 1 minute read Hiring News News Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and… byChris-Anne RoqueOctober 10, 2024
Read More 2 minute read Funding News News Therapeutics GRO Biosciences Secures $60.3M in Series B Financing to Advance Protein Therapeutics Key Highlights GRO Biosciences raises $60.3M in Series B financing. Funds to advance lead program for refractory gout… byChris-Anne RoqueJuly 24, 2024
Read More 1 minute read Funding News News Elegen Secures $35M in Series B for DNA Synthesis Key Highlights $35 million Series B round led by Triatomic Capital, featuring GSK and John Ballantyne. Investment to expand ENFINIA™… byChris-Anne RoqueMay 15, 2024